|Articles|September 3, 2019
Harbour BioMed Leverages PPD’s Biotech to Develop Innovative Therapeutics
Advertisement
Harbour BioMed and Pharmaceutical Product Development, LLC have announced that HBM will use the services of PPD’s Biotech to develop innovative therapeutics in the areas of oncology and immunology.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
3
Moving Beyond Historical Site Data to Real-Time Patient Insight
4
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
5